已收盘 10-24 16:00:00 美东时间
0.000
0.00%
Rapt Therapeutics Inc (($RAPT)) announced an update on their ongoing clinical s...
10-25 00:30
RPT:Wells Fargo CEO Charlie Scharf: Credit Will Deteriorate Over Time, We Just ...
10-23 01:19
RAPT Therapeutics (NASDAQ:RAPT) announced on Tuesday that it has commenced an underwritten public offering of shares of its common stock. The company will grant the underwriters a 30-day purchase opt...
10-22 04:17
Rithm Property Trust (NYSE:RPT) declares $0.06/share quarterly dividend, in line with previous. Forward yield 9.6% Payable Nov. 28; for shareholders of record Nov. 14; ex-div Nov. 14. See RPT Dividend...
10-21 19:35
Shares of Delcath Systems Inc (NASDAQ:DCTH) rose sharply in pre-market trading ...
10-20 17:10
Radiopharm Theranostics Limited has secured firm commitments for a A$35 million capital raise via a private placement at A$0.03 per share, with Lantheus investing A$7.6 million. A Share Purchase Plan will raise up to A$5 million from eligible shareholders. Participants will receive one free attaching option per share, exercisable at A$0.039 until October 2027. Proceeds will fund drug manufacturing, clinical trials, and working capital, extending ...
10-20 11:30
RAPT Therapeutics, Inc. (NASDAQ: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that the U.S.
09-29 17:01
当时间的指针拨向五年前,中国医疗健康产业已经开始了前所未有的深刻变革:政策顶层设计向“创新”倾斜,市场规则被“价值”重塑,本土产业高速发展。 对于长...
09-26 11:49
Rapport Therapeutics is conducting a $250 million underwritten public offering of its common stock, with an option for underwriters to purchase an additional $37.5 million. The offering is subject to market conditions and has been filed with the SEC under a shelf registration statement. Rapport Therapeutics focuses on developing small molecule precision medicines for neurological and psychiatric disorders, utilizing its RAP technology platform to...
09-08 20:05
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 来源:红刊财经 文丨张桔 创新药板块不仅产业逻辑出圈,中报财务层面也...
09-05 16:19